БИОЛОГИЧЕСКАЯ РОЛЬ ЦИНКА ПРИ АЛКОГОЛЬНОМ И ВИРУСНОМ ПОРАЖЕНИЯХ ПЕЧЕНИ (обзор литературы)
https://doi.org/10.51523/2708-6011.2013-10-2-2
Аннотация
Об авторах
В. М. ШейбакБеларусь
М. В. Горецкая
Беларусь
А. Ю. Павлюковец
Беларусь
Список литературы
1. Zinc metabolism in alcoholic liver disease. / C. J. McClain, [et al.] // Alcohol. Clin. Exp. Res. - 1986. - Vol. 10. - P. 582-589.
2. Boyett, J. D. Zinc and cоllagen content of cirrhotic liver / J. D. Boyett, J. F. Sullivan // Dig. Dis. - 1970. - Vol. 15, № 9. - P. 797-803.
3. Zinc homeostasis and signaling in health and disease / T. Fukada [et al.] // J Biol. Inorg. Chem. - 2011. - Vol. 16. - P. 1123-1134.
4. Wang, X. Dietary zinc absorption: a play of Zips and ZnTs in the gut / X. Wang, B. Zhou // Life. - 2010. - Vol. 62, № 3. - P. 176-182.
5. King, J. C. Zinc: an essential but elusive nutrient / J. C. King // Am. J. Clin. Nutr. - 2011. - Vol. 94. - P. 679-684.
6. Effects of endotoxin on zinc metabolism in human volunteers / L. Gaetke [et al.] // Am. J Physiol. - 1997. - Vol. 272. - P. 952-956.
7. Molecular dissection of the structural machinery underlying the tissue-invasive activity of MT1-MMP / X. Y. Li [et al.] // Mol. Biol. Cell. - 2008. - Vol. 19. - P. 3221-3233.
8. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat / T. Knittel [et al.] // Histochem. Cell. Biol. - 2000. - Vol. 113. - P. 443-453.
9. Шейбак, Л. Н. Биологическая роль цинка и перспективы медицинского применения цинк-содержащих препаратов: монография / Л. Н. Шейбак, В. М. Шебак. - Гродно, 2003. - С. 82.
10. Jacobson, B. P. M. Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines / B. P. M. Jacobson, M. G. Neuman // Clin. Biochem. - 2001. - Vol. 34. - P. 167-171.
11. McClain, C. J. Zinc deficiency in the alcoholic / C. J. McClain, L-C. Su // Alcohol. Clin. Exp. Res. - 1984. - Vol. 7. - P. 5-10.
12. Cherian, M. G. Metallothionein and Liver Cell Regeneration / M. G. Cherian, Y. J. Kang // Exp. Biol. Med. - 2006. - Vol. 231. - P. 138-144.
13. Oliver, J. R. Impaired hepatic regeneration in metallothionein-I/II knockout mice after partial hepatectomy / J. R. Oliver, T. W. Mara, M. G. Cherian // Exp. Biol. Med. (Maywood). - 2005. - Vol. 230, № 1. - P. 61-67.
14. Cherian, M. G. Nuclear localization of metallothionein during cell proliferation and differentiation / M. G. Cherian, M. D. Apostolova // Cell. Mol. Biol. (Noisy-le-grand). - 2000. - Vol. 46, № 2. - P. 347-356.
15. Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease / M. Consolo [et al.] // Int. J. Mol. Med. - 2009. - Vol. 24. - P. 143-152.
16. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes / V. Jarousse [et al.] // Eur. J. Dermatol. - 2007. - Vol. 17. - P. 492-496.
17. Reinhold, D. Zinc regulates DNA synthesis on IL-2, IL-6, and IL-10 production of PWM-stimulated PBMC and normalizes the peripheral cytokine concentration in chronic liver disease / D. Reinhold, S. Ansorge, K. Grungreiff // J. Trace. Elem. Exp. Med. - 1997. - Vol. 10. - P. 19-27.
18. Zinc is essential for binding of p561ck to CD4 and CD8alpha / R. S. Lin [et al.] // J. Biol. Chem. - 1998. - Vol. 273. - P. 878-882.
19. Metallothionein expression and concentrations of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma / T. Tashiro-Itoh [et al.] // Liver. - 1997. - Vol. 17. - P. 300-306.
20. The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction / W. Zhong [et al.] // Am. J. Physiol. Gastrointest. Liver Physiol. - 2010. - Vol. 298, № 5. - P. 625-633.
21. Godde, H. F. Relation between zinc status and hepatic functional reserve in patients with liver disease / H. F. Godde, J. Kelleher, B. E. Walker // Gut. - 1990. - Vol. 31. - P. 694-697.
22. Preservation of hepatocyte nuclear factor4alpha is associated with zinc protection against TNF-alpha hepatotoxicity in mice / Z. Zhou [et al.] // Exp. Biol. Med (Maywood). - 2007. - Vol. 232, № 5. - P. 622-628.
23. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy / B. Gorg [et al.] // Hepatology. - 2011. - Vol. 54, № 1. - P. 204-215.
24. Gurusamy, K. Trace element concentration in metastatic liver disease: a systematic review / K. Gurusamy, B. R. Davidson // J. Trace. Elem. Med. Biol. - 2007. - Vol. 21. - P. 169-177.
25. Пронько, С. П. Влияние цинка на метаболизм алкоголя в организме животных / С. П. Пронько, В. М. Шейбак // Медицинские и социально-психологические проблемы алкогольной и наркотической зависимости мат. 1-й Российско-Белорусской конф. - Витебск, 2002. - С. 101-103.
26. Kang, Y. J. Zinc prevention and treatment of alcoholic liver disease / Y. J. Kang, Z. Zhou // Mol. Aspects Med. - 2005. - Vol. 26, № 4. - P. 391-404.
27. Zinc supplementation inhibits hepatic apoptosis in mice subjected to long-term ethanol exposure / Z. Zhou [et al.] // Exp. Biol. Med. (Maywood). - 2008. - Vol. 223, № 5. - P. 540-548.
28. Serum and tissue concentrations of zinc after oral supplementation in chronic alcoholics with or without cirrhosis / J. P. Zarski [et al.] // Gastroenterol. Clin. Biol. - 1987. - Vol. 11. - P. 856-860.
29. Nutritional effects of oral zinc supplementation in cirrhosis / G. P. Bianchi [et al.] // Nutr Res. 2000. - Vol. 20. - P. 1079-1089.
30. Beier, J. I. Advances in alcoholic liver diseases / J. I. Beier, G. E. Arteel, C. J. McClain // Curr. Gastrol. Rep. - 2011. - Vol. 13, № 1. - P. 56-64.
31. Rink, L. Zinc homeostasis and immunity / L. Rink, H. Haase // Trends Immunol. - 2007. - Vol. 28. - P. 1-4.
32. Шейбак, В. М. Влияние цинк аспартата, таурина и «тауцина» на фагоцитарную активность нейтрофилов крови крыс / В. М. Шейбак, И. В. Данильчик // Актуальные проблемы медицины: сб. ст. - Гродно, 2009. - С. 327-329.
33. Шейбак, В. М. Иммуногепатология. Роль печени в иммунной системе / В. М. Шейбак, М. В. Горецкая. - М.: Пальмир, 2010. - 256 с.
34. Moneib, H. A. Evaluation of zinc level in skin of patients with encrolytic acral erythema / H. A. Moneib, S. A. Salem, M. M. Darwish // Br. J. Dermatol. - 2010. - Vol. 163, № 3. - P. 476-480.
35. Spengler, U. Immunopathogenesis of hepatitis C cirrhosis / U. Spengler, J. Nattermann // Clin. Sci. - 2007. - Vol. 12. - P. 141-155.
36. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease / T. Himoto [et al.] // Scand. J. Gastroenterol. - 2007. - Vol. 42. - P. 1078-1087.
37. Zinc supplementation prevents the increase of transaminase in chronic hepatitis C patients during combination therapy with pegylated interferon alpha-2b and ribavirin / Y. Murakami [et al.] // J. Nutr. Sci. Vitaminol. - 2007. - Vol. 53. - P. 213-218.
38. Sun, B. NF-B signaling, liver disease and hepatoprotective agents / B. Sun, M. Karin // Oncogene. - 2008. - Vol. 27. - P. 6228-6244.
39. Zinc is a negative regulator of hepatitis C virus RNA replication / K. Yuasa [et al.] // Liver. Int. - 2006. - Vol. 26. - P. 1111-1118.
40. Serum zinc as a factor predicting response to interferon-alpha2b therapy in children with chronic hepatitis B / E. Ozbal [et al.] // Biol. Trace. Elem. Res. - 2002. - Vol. 90, № 3. - P. 31-38.
41. Evaluation of distribution patterns for copper and zinc in metallothionein and superoxide dismutase in chronic liver diseases and hepatocellular carcinoma using high-performance liquid chromatography (HPLC) / S. Kubo [et al.] // Biol. Pharm. Bull. - 2005. - Vol. 28, № 7. - P. 1137-1141.
42. Franklin, R. B. Zinc as an anti-tumor agent in prostate cancer and in other cancers / R. B. Franklin, L. C. Costello // Arch. Biochem. Biophys. - 2007. - Vol. 463. - P. 211-217.
43. Zip4 (Slc39a4) expression is activated in hepatocellular carcinomas and functions to repress apoptosis, enhance cell cycle and increase migration / B. P. Weaver [et al.] // PLoS. One. - 2010. - Vol. 5, № 10. - P. 131-158.
44. Congenital zinc deficiency from mutations of the SLC39A4 gene as the genetic background of acrodermatitis enteropathica / C. H. Park [et al.] // J. Korean. Med. Sci. - 2010. - Vol. 25, № 12. - P. 1818-1820.
45. Chronic zinc deficiency syndrome in a beer drinker with a Billroth II resection / K. Weismann [et al.] // Int. J. Dermatol. - 1976. - Vol. 15. - P. 757-761.
46. Clinical trial: oral zinc in hepatic encephalopathy / Y. Takuma [et al.] //Aliment. Pharmacol. Ther. - 2010. - Vol. 32, № 9. - P. 1080-1090.
47. Dejong, C. H. Muscle ammonia and glutamine exchange during chronic liver insufficiency in the rat / C. H. Dejong, N. E. Deutz, P. B. Soeters // J. Hepatol. - 1994. - Vol. 21. - P. 299-307.
48. Kumari, D. Effect of dietary zinc deficiency on testes of Wistar rats: morphometric and cell quantification studies / D. Kumari, N. Nair, R. S. Bedwal // J. Trace. Elem. Med. Biol. - 2010. - Vol. 25, № 1. - P. 47-53.
49. Zinc status and serum testosterone levels of healthy adults / A. S. Prasad [et al.] // J. Nutrition. 1996. - Vol. 12, № 5. - P. 344-348.
50. Croxford, T. P. Moderate zinc deficiency reduces testicular Zip6 and Zip10 abundance and impairs spermatogenesis in mice / T. P. Croxford, N. H. McCormick, S. L. Kelleher // J. Nutr. - 2011. - Vol. 141, № 3. - P. 359-365.
Рецензия
Для цитирования:
Шейбак В.М., Горецкая М.В., Павлюковец А.Ю. БИОЛОГИЧЕСКАЯ РОЛЬ ЦИНКА ПРИ АЛКОГОЛЬНОМ И ВИРУСНОМ ПОРАЖЕНИЯХ ПЕЧЕНИ (обзор литературы). Проблемы здоровья и экологии. 2013;(2):14-20. https://doi.org/10.51523/2708-6011.2013-10-2-2
For citation:
Sheibak V.M., Goretskaya M.V., Pavliukovets A.Yu. BIOLOGICAL ROLE OF ZINC IN ALCOHOLIC AND VIRAL LIVER LESION (literature review). Health and Ecology Issues. 2013;(2):14-20. (In Russ.) https://doi.org/10.51523/2708-6011.2013-10-2-2